{"DataElement":{"publicId":"2480900","version":"1","preferredName":"Protocol Investigational New Drug Regulation Process Description Text","preferredDefinition":"the free-text field for the description of the Investigational New Drug (IND) number for the agent.","longName":"PR_IND_RE_PR_DES_TXT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2480888","version":"1","preferredName":"Protocol Investigational New Drug Regulation Process Description","preferredDefinition":"information related to the description of an experimental drug used on a clinical trial following FDA approval of an application for testing the drug in people.","longName":"PROT_IND_REG_PRO_DES","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2480876","version":"1","preferredName":"Protocol Investigational New Drug","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.:Status given an experimental drug after the FDA approves an application for testing it in people. (On-line Medical Dictionary)","longName":"C25320:C49135","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Investigational New Drug","conceptCode":"C49135","definition":"A new drug or biological drug that is used in a clinical investigation. The term also includes a biological product that is used in vitro for diagnostic purposes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"135BB582-9A04-73A2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-05-09","modifiedBy":"ONEDATA","dateModified":"2006-05-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2480886","version":"1","preferredName":"Regulation Process Description ","preferredDefinition":"The act of controlling the rate or manner in which a process progresses or a product is formed.:A sequence of events which produces some outcome.:Description; a statement that represents something in words.","longName":"C48805:C29862:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Regulatory Process","conceptCode":"C48805","definition":"A process that acts to control the rate or manner in which another process progresses or a product is formed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Process","conceptCode":"C29862","definition":"A sequence of events which produces some outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"135D2319-9273-0B4E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-05-09","modifiedBy":"ONEDATA","dateModified":"2006-05-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"135D2319-9284-0B4E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-05-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180739","version":"1","preferredName":"Therapy Text","preferredDefinition":"the free-text field related to treatment or therapy.","longName":"TX_TXT","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D221DEFB-B238-0357-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"CAMPBELB","dateModified":"2009-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"IND Title","type":"Preferred Question Text","description":"IND Title","url":null,"context":"CTEP"}],"origin":"CDS:Clinical Data System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"135D5C52-79BD-0B2E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-05-09","modifiedBy":"CAMPBELB","dateModified":"2008-07-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}